MYO News and Press, Myomo Inc. From 08/03/22

Myomo press release ( NYSE: MYO ): Q2 GAAP EPS of -$0.42 beats by $0.01 . Revenue of $3.68M (+18.7% Y/Y) beats by $0.21M . Co says expecting lower year over year revenue in the third quarter. For further details see: Myomo GAAP EPS of -$0.42 beats by ...

Second quarter revenue of $3.7 million up 18% over prior year Cost per pipeline addition cut in half over the last six months Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Com...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial re...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces preliminary second quarter revenue and...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’...

Myomo, Inc. (MYO) Q1 2022 Results Earnings Conference Call May 11, 2022, 04:30 PM ET Company Participants Kim Golodetz - IR, LHA Investor Relations Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Participants Scott Henry - Roth Capital Ben Haynor - ...

Myomo press release (NYSE:MYO): Q1 GAAP EPS of -$0.41 beats by $0.12. Revenue of $3.87M (+65.4% Y/Y) beats by $1.01M. For further details see: Myomo GAAP EPS of -$0.41 beats by $0.12, revenue of $3.87M beats by $1.01M

Revenue of $3.9 million up 66% over prior year, product revenue of $2.9 million up 23% Pipeline of 924 MyoPro candidates up 14% over fourth quarter of 2021 Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NYSE American: MYO) (“My...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial re...

Medical robotics firm Myomo (NYSE:MYO) said its Chinese joint venture firm Jiangxi Myomo Medical Assistive Appliance had paid a portion of the technology license fee. The company said it received $1M of the total $2.7M license fee during March, which will be accounted for as revenue duri...